Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Recipharm names 2017 International Environmental Award winner

    Mar 13, 2018, 10:00 AM by Michael Croft
    STOCKHOLM, SWEDEN - Mar 13, 2018 - Recipharm has announced that its 2017 International Environmental Award will be presented to Karen Kidd, Professor in Biology, and Geography & Earth Sciences at McMaster University in Hamilton, Ontario and Jarislowsky Chair in Environment and Health
    Full story
  • From App Store To Drug Store, Digital Health Is Redefining Pharma’s Pipeline

    Mar 13, 2018, 08:50 AM by Michael Croft
    STAT | Backed by a growing body of evidence, software is itself becoming a prescription for diseases ranging from depression to heart disease, and drug companies are starting to take notice.
    Full story
  • Rob Brainin Named New CEO at WuXi NextCODE

    Mar 12, 2018, 17:00 PM by Michael Croft
    Bio-IT World News Brief | WuXi NextCODE has named a new CEO: Rob Brainin, Executive Vice President and Chief Operating Officer, has been appointed as the company’s new Chief Executive Officer effective today. Brainin succeeds Hannes Smárason, who will work as a senior advisor for the company as he pursues other entrepreneurial activities, according to the company.
    Full story
  • Certara and Faculty from UNC Eshelman School of Pharmacy to Launch New Pharmacometrics Skills Competition at ASCPT 2018 Annual Meeting

    Mar 12, 2018, 08:26 AM by Michael Croft
    PRINCETON, NJ - Mar 12, 2018 - Mar. 12, 2018 – Certara®, the global leader in model-informed drug development and regulatory science, today announced that it is partnering with faculty at the UNC Eshelman School of Pharmacy to launch the Model-informed Drug Development (MIDD) Gran Prix at the 2018 American Society for Clinical Pharmacology & Therapeutics (ASCPT) Annual Meeting
    Full story
  • Domainex appoints Dr Bodo Spori as Head of Business Development for Europe

    Mar 12, 2018, 05:48 AM by Michael Croft
    CAMBRIDGE, UK - Mar 12, 2018 - Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe
    Full story
  • AI Has a Hallucination Problem Thats Proving Tough to Fix

    Mar 9, 2018, 12:36 PM by Michael Croft
    WIRED | Machine learning systems, like those used in self-driving cars, can be tricked into seeing objects that don't exist. Defenses proposed by Google, Amazon, and others are vulnerable too.
    Full story
  • Bioclinica Wins Clinical Informatics News Best Practices Award for ‘Transformational Medical Imaging in Clinical Trials: SMART Submit’

    Mar 9, 2018, 11:35 AM by Michael Croft
    PRINCETON, NJ, US - Mar 7, 2018 - Bioclinica®, the world-leading provider of scientific- and technology-enabled solutions for clinical research, is pleased to announce its cloud-based research image management technology, 'SMART Submit,' was recognized with a Clinical Informatics News Best Practices Award
    Full story
  • Clinithink’s CLiX natural language processing solution plays a key role in achieving a GUINNESS WORLD RECORDS™ title for fastest genetic diagnosis

    Mar 8, 2018, 11:48 AM by Michael Croft
    LONDON, UNITED KINGDOM - Mar 8, 2018 - Clinithink has helped to achieve a GUINNESS WORLD RECORDS title for the Fastest genetic diagnosis
    Full story
  • WuXi NextCODE Announces Genomics Partnership with Google Cloud

    Mar 7, 2018, 12:00 PM by Michael Croft
    Bio-IT World  | WuXi NextCODE today announced a partnership with Google Cloud. WuXi NextCODE’s core suite of capabilities—including GORdb, WuXi NextCODE secondary analysis, the Sequence Miner case-control research application, and the Clinical Sequence Analyzer clinical interpretation system—will be hosted on Google Cloud and available on the Google Cloud Launcher marketplace.
    Full story
  • 2bPrecise and The Innovation Institute to Deliver Robust Pharmacogenomics Platform, GeneFolio, to the Point of Care

    Mar 7, 2018, 11:22 AM by Michael Croft
    NEWTON, MA, UNITED STATES - Mar 7, 2018 - HIMSS 2018 - LAS VEGAS - March 7, 2018 - 2bPrecise®, LLC, and The Innovation Institute announced today that they have entered into an agreement that lays the foundation for 2bPrecise to deliver a pharmacogenomics knowledge base to the point of care for The Innovation Institute's network of member providers, as well as others beyond the network
    Full story
  • Medherant expands team with appointment of David Davies as Head of Development

    Mar 7, 2018, 05:30 AM by Michael Croft
    COVENTRY, UK - Mar 7, 2018 - Medherant Ltd, a leader in next-generation transdermal drug delivery, is pleased to announce the appointment of a new senior executive, David Davies, as Head of Development
    Full story
  • BC Platforms Launches an End-to-End Solution for Precision Medicine powered by the Microsoft Genomics Service

    Mar 7, 2018, 03:27 AM by Michael Croft
    BOSTON, MA - Mar 7, 2018 - BC Platforms, a pioneer in genomic data management and analytics, today announces it has launched GeneVision, a new end-to-end Solution for Precision Medicine, that uses the Microsoft Genomics service which runs on Microsoft Azure
    Full story
  • FDA Authorizes 23andMe BRCA Consumer Test

    Mar 6, 2018, 12:50 PM by Michael Croft
    Bio-IT World News Brief | FDA today authorized a direct-to-consumer genetic test for cancer risk. The authorization allows 23andMe to provide customers, without a prescription, information on three genetic variants found on the BRCA1 and BRCA2 genes known to be associated with higher risk for breast, ovarian, and prostate cancer.
    Full story
  • Shivom Partnership With Genetic Technologies Will Enable Better Cancer Prediction and Prevention Through Mass Genomic Data Analysis

    Mar 6, 2018, 09:37 AM by Michael Croft
    MELBOURNE, AUSTRALIA - Mar 6, 2018 - Shivom, the blockchain-powered global ‘Unique ID’ genomic database platform, has today announced a major partnership with leading molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) that is expected to accelerate the prediction of cancer for millions of individuals worldwide
    Full story
  • Gene By Gene Selects BC Platforms to enhance its world leading Genomic data processing services

    Mar 6, 2018, 05:43 AM by Michael Croft
    BOSTON, MA - Mar 6, 2018 - BC Platforms, a world leader in genomic data management and analytics, announces that it has been selected by Gene By Gene, the industry leader in offering integrated multi-disciplinary genetic testing services, to scale up its genomic data processing and storage capabilities
    Full story
  • Ballot is Open For 2018 Benjamin Franklin Award Winner

    Mar 5, 2018, 13:50 PM by Michael Croft
    Bio-IT World Bioinformatics.org has announced five finalists for the 2018 Benjamin Franklin Award for Open Access in the Life Sciences, including the first finalist team. Voting will be open until Monday, March 12. Finalists are Christine Durinx, SIB Swiss Institute of Bioinformatics & Johanna McEntyre, EMBL-EBI; Melissa Haendel, Oregon Health and Science University; Desmond Higgins, University College Dublin (UCD) Conway Institute; B.F. Francis Ouellette, Ontario Institute of Cancer Research; and Frank W. Rockhold, Duke University Medical Center.
    Full story
  • The Latest in Data Integration and Personalized Medicine: Updates from the 2018 Molecular Medicine Tri-Conference

    Mar 5, 2018, 12:30 PM by Michael Croft

    Bio-IT World  In San Francisco last month, Bio-IT World caught up with leaders in data management and cloud computing at Tri-Con’s Converged IT & the Cloud track. In a series of talks and panel discussions, they shared their experiences dealing with the challenges of storing, transferring and integrating vast amounts of data from a broad range of sources.

    Full story
  • The Man Who Uncovered a New (Old) Way to Fight Cancer

    Mar 5, 2018, 10:39 AM by Michael Croft
    MIT Technology Review | Matthew Vander Heiden helped revive the forgotten- but critical-study of cancer metabolism.
    Full story
  • MDI Biological Laboratory Launches New Course on Organoid Technology

    Mar 5, 2018, 09:46 AM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Mar 5, 2018 - The MDI Biological Laboratory in Bar Harbor, Maine, has announced that it will offer a one-week intensive course May 27 through June 2, 2018 entitled “Applications of Organoid Technology” in partnership with Hubrecht Organoid Technology (The HUB), a non-profit organization based in Utrecht, Netherlands
    Full story
  • BioIVT Launches New Website, Highlighting Expanded Biospecimen Product and Service Portfolios for Drug Development Researchers

    Mar 5, 2018, 08:12 AM by Michael Croft
    WESTBURY, NY - Mar 5, 2018 - BioIVT, a leading provider of biospecimens and related services, today announced the launch of its comprehensive, new, user-friendly website at www
    Full story
  • «
  • 271
  • 272
  • 273
  • 274
  • 275
  • 276
  • 277
  • 278 (current)
  • 279
  • 280
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy